The application is based on Phase II and III clinical trial contract milestones from leading biopharma companies and CROs.
CHICAGO, Illinois, January 18, 2018 – KMR Group, a leader in analyzing R&D performance data for the biopharmaceutical R&D industry, is pleased to announce the launch of the Site Contracts Application. Assessing global pharma Industry site contract cycle times, the application consists of milestone information for over 100,000 clinical contracts from nearly 100 countries.
With increasingly complex and long cycle times for investigative sites clinical trial contracts, the Site Contracts Application provides previously unavailable Industry contract benchmarks to help companies reduce their contract cycle times and inform their plans based on disease and location. The application is based on Phase II and III clinical trial contract milestones from leading biopharmaceutical companies and CROs.
KMR Group’s Site Contracts Study has long been evaluating trends in site contract milestones. Using the company’s expertise in assessing site contract performance and developing applications to help access the data, this new tool helps Industry decision makers with data to compare contract performance by study phase, type of site (independent, institution), budget cycle time, therapy area, region and country level performance.
As with all applications created by KMR Group, the application not only provides the Industry benchmarks, but also shows each company’s performance ranked against other major companies in the Industry. Over 20 companies are represented in the application, with contracts going back to 2010.
“The Site Contracts Application offers a critical missing piece to the study planning puzzle. Anyone involved with incorporating site contract cycle times into overall trial plans will benefit by having this proprietary performance information at their fingertips,” commented Linda Martin, President and Founder of KMR Group.
For questions about accessing the Site Contracts Application contact:
Lyndsey McKay, Associate Director, Marketing Tel: +1 (312) 795-0400 Email: lmckay [at] kmrgroup.com
About KMR
KMR Group has worked exclusively in biopharmaceutical R&D since the early 1990s. KMR Group is an industry leader in benchmarking, analytics and performance management as well as a developer of on-line analytics tools that enable access to propriety and rich datasets. KMR’s clinical platform contains the most reliable source for trial performance, recruitment and site metrics data, with nearly 30,000 global clinical trials. Clients depend on these tools to benchmark performance, define recruitment strategies and shape enrollment plans and to identify best performing sites.
Visit our website at https://kmrgroup.com
Follow us on Twitter @KMRGroupInc
